NCT07652684招募中4 期
Enteral Lipid Supplementation and Bronchoplumonary Dysplasia of Premature Infants: A Randomized Controlled Trial (The PRELUDE Trial)
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 入组人数
- 74
- 试验地点
- 1
研究概览
简要总结
The Impact of Omega-3 (DHA - Docosahexaenoic Acid) and Omega-6 (ARA - Arachidonic Acid) Supplementation on the Development of Bronchopulmonary Dysplasia in Extremely and Very Preterm Infants (24-29 weeks of gestational age).
详细描述
The intervention group will receive enteral supplementation with ARA and DHA (in a 2:1 ratio) in addition to standard care and feeding, while the control group will receive standard care and feeding. The intervention will commence within the first three days of life and will continue until 36 weeks postmenstrual age for both groups.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Single (Participant)
盲法说明
The statistician will also be masked.
入排标准
- 年龄范围
- 24 Weeks 至 29 Weeks（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Infants born at Papageorgiou Hospital in Neonatology Department and NICU of Aristotle University of Thessaloniki with GA equal to or less than 29 weeks are eligible to participate in the study.
排除标准
- •Congenital malformations, chromosomal abnormalities or critical illness with short life expectancy.
- •Study participation requires written informed parental consent within 48h after birth.
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Effects of Omega-3 Fatty Acids on Inflammation and Gut Microbiota in Celiac DiseaseCeliac DiseaseNCT07585669University of Chile40
尚未招募
3 期
Effect of Low-Dose Versus High-Dose Alpha-Lipoic Acid on Oxidative Stress, Inflammation, and Clinical Outcomes in Acute Exacerbations of Chronic Obstructive Pulmonary DiseaseNCT07456176Ain Shams University75
尚未招募
3 期
Trial on effectiveness of omega-3 fatty acid supplements compared to Steroids in treating Lichen Planus of mouthCTRI/2024/11/076144Medona Antony42
招募中
不适用
Omega-3 Fatty Acids, Inflammation, Gut Microbiota in Youth With DepressionNCT07363551China Medical University Hospital60
进行中（未招募）
不适用
oral supplementation of Omega 3 fattyacids and low dose asprin in type-II diabetic patientsCTRI/2024/10/074974SIBAR Institute of dental sciences40